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A central question about human brain aging is
whether cognitive enrichment slows the develop-
ment of Alzheimer changes. Here, we show that pro-
longed exposure to an enriched environment (EE)
facilitated signaling in the hippocampus of wild-
type mice that promoted long-term potentiation.
A key feature of the EE effect was activation of
b2-adrenergic receptors and downstream cAMP/
PKA signaling. This EE pathway prevented LTP
inhibition by soluble oligomers of amyloid b-protein
(Ab) isolated from AD cortex. Protection by EE
occurred in both young and middle-aged wild-type
mice. Exposure to novelty afforded greater protec-
tion than did aerobic exercise. Mice chronically fed
a b-adrenergic agonist without EE were protected
from hippocampal impairment by Ab oligomers.
Thus, EE enhances hippocampal synaptic plasticity
by activating b-adrenoceptor signaling and miti-
gating synaptotoxicity of human Ab oligomers.
These mechanistic insights support using prolonged
exposure to cognitive novelty and/or oral b-adren-
ergic agonists to lessen the effects of Ab accumula-
tion during aging.
INTRODUCTION
Rodents living in a simple laboratory environment access only
food and water. Adding multiple novel objects and running
wheels to their cages, referred to as environmental enrichment
(EE), has been shown in many studies to improve memory and
its neuroanatomical and biochemical substrates. Humans who
develop AD invariably accumulate Ab in limbic and association
cortices and undergo an insidious erosion of memory and
cognition. Mice transgenic (tg) for human APP (the precursor
of Ab) that are exposed to EE generally show an improvement
in cognitive deficits compared to tg mice in standard housing(SH) (Arendash et al., 2004; Jankowsky et al., 2005; Wolf
et al., 2006; Berardi et al., 2007; Costa et al., 2007; Valero
et al., 2011; see Table S1 available online). However, these
studies perforce include EE effects on the processing of
markedly overexpressed mutant APP in models of rare genetic
forms of AD, making it impossible to separate the neuroprotec-
tive effects of EE from effects on the profound Ab pathology
such animals have. The vast majority of AD cases suffer the
late-onset, largely ‘‘sporadic’’ form of the disease, whereas
a very small number of familial cases are caused by determin-
istic genetic mutations. These and other data suggest that envi-
ronmental factors may play a role in the development of many
cases of typical (late-onset) AD. Experimentally, soluble Ab
oligomers, including those isolated directly from AD brain
tissue, have been shown to potently block hippocampal long-
term potentiation (LTP), an electrophysiological correlate of
learning and memory, whereas insoluble amyloid plaque cores
have far less bioactivity (Selkoe 2002; Walsh et al., 2002;
Shankar et al., 2008; Wilcox et al., 2011). The negative effects
of Ab oligomers on hippocampal LTP provide a widely validated
experimental system for deciphering some of the mechanisms
of early AD pathogenesis (Nalbantoglu et al., 1997; Klyubin
et al., 2011).
While a few studies have examined the effects of EE on APP
processing and Ab economy in tg mice strongly overex-
pressing human APP (Table S1), we are unaware of reports
on whether EE can alter the vulnerability of wild-type adult
neurons to the synaptic effects of soluble Ab oligomers, which
are believed to mediate neurotoxicity in AD (Selkoe 2002).
Studying the effects of EE in wild-type animals exposed to
human Ab oligomers can better model the early develop-
ment of Ab-mediated neurotoxicity in the majority of humans
without a deterministic genetic predisposition to AD. It is
in such patients that chronic environmental factors are
likely to play an important role in AD pathogenesis. Here,
we report that activation of b-ARs by exposing normal mice,
including mature adults, to 2 months of environmental novelty
fully prevents the impairment of hippocampal synaptic
plasticity by Ab oligomers, and this protection can be mim-
icked by prolonged feeding of a b-adrenergic agonist
without EE.Neuron 77, 929–941, March 6, 2013 ª2013 Elsevier Inc. 929
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Figure 1. Prolonged Exposure to an En-
riched Environment (EE) Enlarges Dendritic
Spines and Enhances Hippocampal Long-
Term Potentiation
(A) Representative Golgi stains and quantifica-
tion: hippocampal dendritic spine area, length
and volume, but not density, were significantly
increased by EE training. Scale bar, 5 mm. (*p <
0.05; **p < 0.01).
(B) The presynaptic proteins, synapsin I and
synaptophysin, were unchanged in response to
EE, while the postsynaptic protein, PSD95, rose
significantly (**p < 0.01) in both synaptosome and
cytosol fractions of hippocampus.
(C) EE significantly increased LTP induced by high
frequency stimulation (HFS, arrow) in the CA1
region of hippocampal slices (red circles, n = 28
slices/from 25 mice) versus those of mice in
standard housing (SH) (black diamonds, n =
13/13).
(D) EE significantly increased LTP induced by
theta-burst stimulation (TBS, arrow) of hippo-
campal slices (red circles, n = 15/12) versus those
in SH (black diamonds, n = 11/10). Data are
means ± SEM. Inset traces are typical field excit-
atory postsynaptic potentials (fEPSPs) recorded
before (gray) and after (black or red) HFS or TBS.
Horizontal bars: 10 ms; vertical bars: 0.5 mV.
See also Figure S1.
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Environmental Novelty Prevents Ab-Impaired LTPRESULTS
EE Enlarges Dendritic Spines and Enhances
Hippocampal LTP
We first investigated the potential benefits of exposure to EE on
the synaptotoxicity of soluble Ab oligomers by initiating EE
training at age 14 days and continuing daily for 4weeks, because
EE exposure during postnatal development is known to have
greater benefits than in adult mice (Escorihuela et al., 1994;
Cancedda et al., 2004; Li et al., 2006). Six to eight outbred
wild-type (WT) mice (C57Bl/6 3 129) were housed together for
8 hr per day 7 days per week in a large cage (383 60 cm) having
several different brightly colored mouse toys and a running
wheel (see Experimental Procedures). To encourage active
exploration of a novel environment, new toys were swapped
for existing ones every day. The activity of the individual mice
(exploring the objects and/or running on a wheel) was monitored
2–4 times during each 8 hr EE training session; a very few
animals that persistently showed no interest in exploratory or930 Neuron 77, 929–941, March 6, 2013 ª2013 Elsevier Inc.running activity were removed from the
EE groups. Control littermate mice were
housed in the same room in standard
cages with only bedding and access to
water and food pellets (SH).
To verify that the neural effects of our
EE protocol were generally consistent
with those in prior studies, we assessed
morphological and biochemical changes
in the hippocampus after the 4 week
EE exposure using Golgi impregnation,BrdU staining, quantitative western blotting (WB) of synaptic
proteins, and electrophysiology. Golgi staining showed that EE
training significantly increased the length and area of dendritic
spines of pyramidal neurons in CA1 of hippocampus, resulting
in a mean increase in spine volume of 151% compared to SH
littermates, i.e., from 2.42 mm3 to 3.66 mm3 (Figure 1A), while
astrocyte numbers did not appear to change (Figure S1A).
Next, we isolated the synaptic membrane-enriched fraction
(synaptosomes) and the high-speed cytosol fraction from both
hippocampus and cerebral cortex of EE and SH mice
and performed quantitative WB for the presynaptic proteins
synapsin I and synaptophysin; no significant differences were
found (Figures 1B and S1C). Electrophysiological recordings
were consistent with the latter finding, as paired-pulse facilita-
tion, a measure of presynaptic efficacy, was at similar levels in
hippocampal slices of mice with versus without EE exposure
(Figure S1B). In contrast, levels of the postsynaptic protein
PSD95 rose 80% in hippocampus in the EE mice (Fig-
ure 1B); there was no significant change in the cerebral cortex
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Figure 2. EE Increases the Frequency of
Miniature Excitatory Postsynaptic Currents
(mEPSC) in CA1 Neurons and the Phosphor-
ylation of AMPAR Subunit GluA1 at S845
(A) Representative voltage-clamp recordings (A1)
from pyramidal neurons in SH (black) and EE mice
(red) and summary data (A2).
(B) Neuronal receptors implicated in synaptic
plasticity and memory (GluN1, GluN2A, GluN2B,
GluA1, and pGluA1) were analyzed by quantitative
WB after 4 week EE training. Representative
blots show the protein levels from hippocampal
synaptosomes (B1). Summary data (bars) are
shown on (B2).
Error bars are ±SEM (*p < 0.05; **p < 0.01). See
also Figure S2.
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Environmental Novelty Prevents Ab-Impaired LTP(Figure S1C). Hippocampal LTP, a sensitive and readily quantifi-
able electrophysiological correlate of synaptic plasticity, was
significantly increased by EE, as shown by the magnitude of
LTP induced by either a high-frequency stimulus (HFS) or
theta-burst stimulation (TBS) versus that in SH mice (HFS:
187% ± 9%, n = 28 slices/from 25 mice, versus 158% ± 4%,
n = 13/13; TBS: 167% ± 5%, n = 15/12, versus 148% ± 6%,
n = 11/10; p < 0.05; Figures 1C and 1D), confirming previous
reports (Foster et al., 1996; Duffy et al., 2001; Artola et al.,
2006; Li et al., 2006; Hu et al., 2010; Malik and Chattarji, 2012).
EE significantly increased the number of BrdU+ newborn
neurons in the dentate gyrus by 289% (Figure S1D). Taken
together, these various results indicate that our EE training
protocol is effective in enhancing certain neural substrates of
memory and learning in these wild-type mice, consistent with
published EE studies.
EE Increases the Frequency of Miniature EPSCs
and the Level of GluA1 pS845
To more fully characterize the neuronal effects of our EE
paradigm, we performed patch-clamp whole-cell recordings
that compared the frequency and amplitude of spontaneous
miniature excitatory postsynaptic currents (mEPSCs) in CA1
pyramidal neurons of SH and EE mice. Voltage-clamp record-
ings showed that the mEPSC frequency increased after EE
(SH: 0.35 ± 0.05, events/sec, n = 14; EE: 0.56 ± 0.09, events/s,
n = 14; p < 0.01), while mEPSC amplitude remained unchangedNeuron 77, 929–9(SH: 26.23 ± 1.12 pA, n = 14; EE: 26.54 ±
0.70 pA, n = 14; p > 0.05; Figure 2A).
These data suggested that EE increased
neuronal excitation. To assess whether
EE altered basal synaptic transmission,
we measured input/output curves using
extracellular field recordings and found
no significant differences between SH
and EE mice. (Figure S2A). Consistent
with the data that EE increased spine
volume and LTP, biochemical fraction-
ation of hippocampus and quantitative
WB revealed significant increases in the
levels of certain postsynaptic receptors(Figure 2B) and signaling proteins (Figure S2B) in the EE mice.
Although both LTP magnitude and mEPSC frequency were
increased by EE, synaptic AMPAR subunit GluA1 levels did not
change significantly. However, the phosphorylation of GluA1 at
S845 (a PKA binding site) was significantly increased in EE
versus SH mice (Figure 2B), consistent with previous reports
that GluA1 phosphorylation correlates with lowered thresholds
for LTP induction and memory formation (Hu et al., 2007).
Thus, our EE paradigm leads to heightened expression of
certain LTP-related signaling proteins and enhanced GluA1
phosphorylation.
EE Exposure Prevents Impairment of Hippocampal LTP
by Ab Oligomers
To learn whether this EE paradigm can ameliorate the adverse
effects of Ab oligomers on mechanisms of learning and memory,
we studied the acute effects of soluble Ab oligomers from
several different sources on hippocampal LTP. Concentrations
(1–2 nM) of soluble human Ab oligomers in the CM of 7PA2
cells (CHO cells stably expressing the hAPP-V717F AD mutant
[Podlisny et al., 1995]) that fully inhibited LTP in hippocampal
slices of SH mice still allowed a significant and normal LTP in
EE slices (HFS: 108% ± 3%, n = 9/8, versus 145% ± 8%, n =
12/10; TBS: 113% ± 5%, n = 8/8, versus 144% ± 5%, n =
11/10; p < 0.05; Figures 3A and 3B). (The oligomer-rich 7PA2
CM had no significant effect on basal synaptic transmission
in the hippocampal CA1 region in both SH and EE mice41, March 6, 2013 ª2013 Elsevier Inc. 931
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Figure 3. EE Exposure Prevents the Impair-
ment of Hippocampal LTP and Decrease in
Certain Signaling Molecules by Soluble Ab
Oligomers
(A) 7PA2 CM containing soluble human Ab oligo-
mers significantly inhibited HFS-induced LTP in
hippocampal slices of SH mice (black diamonds,
n = 9 slices/8 mice), but this was prevented in
slices of EE-trained mice (red circles, n = 12/10).
Inset: WB (Ab mAbs 6E10+2G3) of the CM shows
the soluble Ab monomers (4 kDa) and SDS-stable
low-n oligomers.
(B) 7PA2 CM significantly inhibited TBS-induced
LTP in SH mice (black diamonds, n = 8/8) but not
EE mice (red circles, n = 11/10).
(C) Synthetic human Ab1-40 S26C dimers (5 nM)
significantly impaired hippocampal LTP in SH
mice (black diamonds, n = 9/5) but not EE mice
(red circles, n = 12/10). Inset: immunoblot of the
(S26C)2 used in the LTP recordings.
(D) IP-SEC fractionation of an AD TBS extract
yielded dimer-rich SEC fraction #9 (inset) that
inhibited HFS-induced LTP in SH mice (pink
traces, n = 8/5), whereas monomer-rich fraction
#12 (inset) did not (gray traces, n = 8/5). In EEmice,
the dimer fraction did not inhibit LTP (red circles,
n = 9/8), just like the monomer fraction (black
diamonds, n = 8/8). Inset traces as in Figure 1.
(E) The decrease in synaptosomal proteins
NMDAR and PSD95 induced by soluble Ab oligo-
mers is prevented by EE training. Left: represen-
tative WBs from hippocampal slices 6 hr after
CHO- CM or 7PA2 CM treatment in SH and EE
mice. Right: summary data from 4 mice in each
group.
Error bars represent ±SEM (*p < 0.05; **p < 0.01).
See also Figure S3.
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Environmental Novelty Prevents Ab-Impaired LTP[Figure S3A].) To confirm this benefit of EE, we tested two other
sources of soluble Ab oligomers: pure, synthetic Ab1-40S26C
cysteine-crosslinked dimers (5 nM), and dimer-rich SEC frac-
tions isolated from TBS-soluble cortical extracts of typical AD
brains (Shankar et al., 2008; Li et al., 2009). The pure (S26C)2
Ab dimers markedly inhibited HFS-induced hippocampal LTP
in SHmice, as expected (Li et al., 2011) (111%± 4%, n = 9/5; Fig-
ure 3C). For EE mice, their enhanced LTP was reduced by the
synthetic dimers, but this still left a substantial and significant
LTP (138 ± 4%, n = 12/10) (Figure 3C). In the case of Ab isolated
directly from AD cortex, dimer-rich but not monomer-rich SEC
fractions impaired LTP in SH mice (110% ± 3%, n = 8/5, versus
148% ± 8%, n = 8/5; p < 0.001) as reported (Li et al., 2011), and
this LTP inhibition was almost fully prevented in the EE mice
(dimers: 146% ± 5%, n = 9/8, versus monomers: 155% ± 4%,
n = 8/8; p > 0.05; Figure 3D). Importantly, LTP in the presence
of the AD brain dimers was statistically indistinguishable from
that in AD brain monomers, which have consistently been shown
to be electrophysiologically neutral (Shankar, et al., 2008; Li
et al., 2009, 2011; Figure 3D). Interestingly, we found that EE
training did not alleviate the known facilitation of hippocampal932 Neuron 77, 929–941, March 6, 2013 ª2013 Elsevier Inc.long-term depression (LTD) by soluble Ab oligomers (Li et al.,
2009) from all 3 Ab sources tested (Figure S3B). Consistent
with our electrophysiological andGolgi data, immunohistochem-
istry and quantitativeWBboth showed that EE training increased
the area of synaptic puncta in the hippocampus (Figure S3C) and
elevated LTP-relevant postsynaptic proteins (certain NMDA
receptors and PSD95) (Figure 3E). In accord, the application of
Ab oligomer-rich 7PA2 CM to SH hippocampal slices lowered
the numbers and areas of synaptic puncta (Figure S3C) as well
as some LTP-related proteins (Figure 3E), but these decreases
were restored to baseline levels in Ab oligomer-treated slices
of mice exposed to EE. Taken together, our results thus far
suggest that EE training for 4 weeks early in life ameliorates
the inhibition of hippocampal LTP by soluble Ab oligomers,
allowing a normal LTP and the restoration of synaptic structure.
EE-Enhanced LTP Requires Activation of b2-Adrenergic
Receptors
Previous studies described an increase in the contribution of
cAMP signaling to LTP induction in the CA1 region of the hippo-
campus after 2–8 week exposures to EE (Duffy et al., 2001;
Neuron
Environmental Novelty Prevents Ab-Impaired LTPLi et al., 2006). Activation of cAMP/PKA signaling by the adenylyl
cyclase activator, forskolin, or the phosphodiesterase type 4
(PDE4) inhibitor, rolipram, can restore the inhibition of LTP by
Ab in culture (Vitolo et al., 2002; Wang et al., 2009) and in APP
tg mice (Gong et al., 2004). These reports could help explain
how EE exposure prevented Ab oligomer-impaired LTP in our
mice. We found that two different PKA inhibitors, KT 5720
(5 mM) or H-89 (20 mM), reduced EE-enhanced LTP to its control
(SH) levels (EE + KT: 140% ± 6%, n = 6/6, versus SH + KT:
138% ± 5% n = 6; EE + H89: 142% ± 5%, n = 8/6, versus
SH + H89: 137% ± 4%; n = 7; Figure 4A). Conversely, activating
PKA by pretreating slices with forskolin (20 mM) prevented the
impairment of LTP by soluble Ab oligomers in slices of SH
mice (FSK + 7PA2 CM: 135% ± 4%, n = 8; 7PA2 CM alone:
108% ± 3%, n = 9; p < 0.001; Figure 4B), thereby mimicking
the benefit of EE. To assess whether the prevention of Ab
oligomer-impaired LTP by EE shares similar mechanisms with
activation of cAMP pathways, we applied forskolin (20 mM) to
EE hippocampal slices 10 min prior to applying 7PA2 CM and
found that the magnitude of LTP was not different from that
with 7PA2 CM alone (Figure 4C). This occlusion experiment
suggests that EE overcomes the detrimental effects of soluble
Ab oligomers in part via cAMP signaling pathways.
A key upstream effector of the PKA signaling pathway is the
b-adrenergic receptor (b-AR). b-ARs are reported to undergo
long-lasting modulation and increased activity after EE training
(Escorihuela et al., 1995; Naka et al., 2002; Cao et al., 2010),
but the electrophysiological effects have not been documented.
To assess to what extent the enhancement of hippocampal LTP
in our EE mice involved the activation of b-ARs, we applied the
non-selective b-AR antagonist, propranolol (5 mM), to their
hippocampal slices and found that LTP was normalized to the
levels in SH mice (EE + prop: 146% ± 5%, n = 12/10, versus
SH: 141% ± 4%, n = 7/7; p > 0.05; Figure 4D). Higher doses of
propranolol dose-dependently inhibited LTP in both SH and EE
hippocampal slices (Figure S4A). To characterize this role of
b-ARs more precisely, we applied a weak HFS (which did not
potentiate synaptic strength in slices of SH mice) to the slices
of EE mice and observed a significant LTP (SH: 112% ± 3%,
n = 14/12, versus EE: 138% ± 3%, n = 25/21; p < 0.001; Fig-
ure S4B). This LTP induced by weak HFS in the EEmice was fully
blocked by either of two b-AR antagonists, propranolol (10 mM)
(110% ± 4%, n = 10/8) or pronethalol (10 mM) (116% ± 5%, n =
7/7; Figure S4B), strongly implicating the activation of b-AR path-
ways in the effects of EE. In accord, treating slices from SHmice
with the b-AR agonist, isoproterenol (iso), allowed a weak HFS
to now induce a significant LTP (iso: 133% ± 4%, n = 8, versus
ACSF: 114% ± 4% n = 8; p < 0.01; Figure S4C), consistent
with a prior report (Gelinas et al., 2008). In agreement with this
finding, pretreatment of SH slices with iso prevented the 7PA2
CM-induced inhibition of standard-HFS LTP (iso + 7PA2 CM:
143% ± 5%, n = 12/10; versus 7PA2 CM alone: 108% ± 3%,
n = 10; p < 0.001; Figure 4E). Iso alone had a small and insignif-
icant effect on LTP (Figure 4E) and had no effect on baseline
fEPSPs over 2 hr (Figure S4D), longer than the time of LTP
recording we used throughout the study. Ab oligomers also did
not affect baseline fEPSPs (Figure S4E). In an occlusion experi-
ment, we applied iso to EE hippocampal slices 10 min prior toapplying 7PA2 CM and found that the magnitude of LTP was
the same as with 7PA2 CM alone, again suggesting that iso
and Ab oligomers share mechanistic pathways (Figure 4C). Iso
also fully prevented the inhibition of HFS-induced LTP by
synthetic S26C dimers in SH slices (dimer + iso: 147% ± 7%,
n = 7; dimer alone: 112% ± 4%, n = 7; p < 0.001; Figure S4F).
Intriguingly, if we treated slices with Ab oligomers 10 min before
the application of iso, there was no restoration of LTP (Fig-
ure S4F, blue triangles). Alternative upstream modulators of
cAMP signaling, namely dopamine agonists (chloro-APB HBr
[5 mM] or SKF 38393 [50 mM]), did not enable weak HFS to induce
a significant LTP in SH slices, in contrast to iso (Figure S4C). In
a pharmacologically specific experiment, the selective b2-AR
antagonist, ICI 118551 (100 nM), but not the selective b1-AR
antagonist, metoprolol (10 mM), fully blocked the weak HFS-
induced LTP in EE mice (ICI: 107% ± 3%, n = 7; metoprolol:
132% ± 5%, n = 8; p < 0.001; Figure 4). Consistent with these
electrophysiological findings, immunoblotting of hippocampal
synaptosomes from EE versus SH mice detected a significantly
increased expression of b2-ARwith EE, but not b1-AR, and dopa-
mine receptors (Figures 4G and 4H) and serotonin and musca-
rinic acetylcholine receptors (Figure S4G). Taken together, these
various results indicate that activation of the b2-AR signaling
pathway in particular can prevent soluble Ab oligomers from
impairing hippocampal LTP in wild-type mice.
Ab Oligomers Inhibit and Induce Internalization
of b2-Adrenergic Receptors
Previous reports showed decreases in the levels of b-ARs and
norepinephrine in several regions of AD brain (Marien et al.,
2004; Szot et al., 2006; Manaye et al., 2013), and Ab-may induce
internalization of b-ARs (Wang et al., 2011). We next examined
the expression of b2-AR and other synaptic proteins in hippo-
campal slices after treatment with soluble Ab oligomers for
increasing times. The phosphorylation of b2-AR at Thr 384,
which is phoshorylated by GRK2 (Fredericks et al., 1996) and
responsible for b2-arrestin-dependent receptor desensitization
(Gurevich and Gurevich, 2006), was increased and the total
expression of b2-AR was decreased in the synaptosomes of
hippocampal slices just 1 hr after administration of 7PA2 CM,
whereas NMDAR and PSD95 were not significantly changed at
this early time (Figure 5A). After 6 hr treatment, the levels of
b2-ARs, NMDARs and PSD95 were all decreased significantly
by the 7PA2 CM but not the control CHO- CM (Figure 5A), while
phosphorylation of b2-AR at Thr384 had returned to normal.
Moreover, surface biotinylation revealed that the cell-derived
soluble Ab oligomers enhanced internalization of b2-AR (but
not b1-AR, dopamine, muscarinic acetylcholine or serotonin
receptors) in cultured rat hippocampal neurons (Figures 5B
and S5). Overall, these results suggest that the activation of
b2-AR by EE can restore impairments of selected synaptic
proteins by soluble Ab oligomers.
Prolonged Feeding of a b-Adrenergic Receptor Agonist
Mimics EE Effects In Vivo
In view of the striking amelioration of Ab-mediated effects on
synaptic plasticity by b-AR manipulation in acute slices, we
extended this approach to the in vivo condition. We added theNeuron 77, 929–941, March 6, 2013 ª2013 Elsevier Inc. 933
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Figure 4. EE-Enhanced LTP Requires Activation of b-Adrenergic Receptors in the CA1 Region of Hippocampus
(A) The enhancement of LTP in EE slices was blocked by applying PKA inhibitors KT5720 (5 mM; black diamonds, n = 6/6) or H-89 (20 mM, red circles, n = 8/6),
bringing the LTP down to levels in SH slices (gray trace).
(B) Activating cAMP signaling with forskolin (FSK, 20 mM) prevented the Ab oligomers in 7PA2 CM from impairing LTP (red circles, n = 8) in SH slices. Gray trace:
SH slices without forskolin pretreatment show the LTP blocked by 7PA2 CM. FSK alone (black diamonds) had no effect on LTP.
(C) Pretreatment with isoproterenol (iso, 10 mM, black diamonds, n = 6) or forskolin (FSK, 20 mM, red circles, n = 6) in hippocampal slices from EE mice does not
further affect the magnitude of HFS-induced LTP in the presence of 7PA2 CM. Pink trace: CHO- CM alone in EE slices; light blue trace: 7PA2 CM alone in
EE slices.
(D) Treating EE slices with the b-AR antagonist propranolol (prop, 5 mM) decreased the EE-enhanced LTP (red circles, n = 12/10) down to the level of SH slices
(black diamonds, n = 7/7). Pink trace: EE slices alone.
(E) The b-AR agonist isoproterenol (iso, 10 mM) prevented the inhibition of LTP by 7PA2CM in SH slices (red circles, n = 12/10), mimicking the effect of EE. Iso itself
did not significantly enhance LTP (black diamonds, n = 13/8). Pink trace: 7PA2 CM alone.
(F) EE-facilitated hippocampal LTP induced by a weak HFS is blocked by the selective b2-AR antagonist ICI 118551 (100 nM, n = 6/8, red triangles), but not by
b1-AR antagonist, metoprolol (10 mM, n = 6/7, black triangles). Theweak HFS induced a significant LTP in slices of EEmice (pink trace), while it failed to induce LTP
in slices of SH mice (gray trace).
(G) Immunoblots of monoamine receptor levels after 4 wk EE training versus in SH. Hippocampal synaptosome and cytosol fractions of fresh brain tissue were
probed with antibodies to b1- or b2-adrenergic receptors or dopamine D1 or D2 receptors. GAPDH, loading control.
(H) Summary data from WB exemplified in (G); expression levels are normalized to GAPDH. Left graph, hippocampal synaptosomes; right graph, hippocampal
cytosol.
Error bars represent ±SEM (*p < 0.05; **p < 0.01). Inset traces in (A)–(F) as in Figure 1. See also Figure S4.
Neuron
Environmental Novelty Prevents Ab-Impaired LTP
934 Neuron 77, 929–941, March 6, 2013 ª2013 Elsevier Inc.
GluN2A
PSD95
β2AR
β2ARp
(Thr384)
GAPDH
1 h 6 h
Non CHO- 7PA2 Non CHO- 7PA2
E
xp
re
ss
io
n 
le
ve
l (
N
or
m
al
iz
ed
 to
 G
A
P
D
H
)
Gl
uN
2A
PS
D9
5
β2-A
R
pβ2
-A
R
Bl
an
k
No
n t
rea
t 6h 18h 24h 24h
CH
O-7PA2 B
lan
k
No
n t
rea
t 6h 18h 24h 24h
CH
O-7PA2
GAPDH
β2AR
β1AR
TR
IB:
Membrane
Lysate
A1 A2
B1
* *
* *
*
1.2
0.8
0.4
0.0
 Non
 CHO-
7PA2
Gl
uN
2A
PS
D9
5
β2-A
R
pβ2
-A
R
1 h 6 h
1.2
0.8
0.4
0.0E
xp
re
ss
io
n 
le
ve
l
 β2AR
 β1AR
No
n t
rea
t
7P
A2
-6h
7P
A2
-18
h
7P
A2
-24
h
CH
O-
 24
h
No
n t
rea
t
7P
A2
-6h
7P
A2
-18
h
7P
A2
-24
h
CH
O-
 24
h
Membrane Lysate
**
**
*
B2
Figure 5. Ab Oligomers Decrease Levels
and Induce Internalization of b2-Adrenergic
Receptors
(A) Levels of b-AR and other synaptic proteins in
the synaptosomes of hippocampal slices after
treatment with Ab oligomers for increasing times.
(A1) Representative WB of protein levels in
hippocampal synaptosomes. (A2) Summary data
(bars) (*p < 0.05).
(B) Soluble Ab from 7PA2 CM induced the selec-
tive internalization of b2-ARs biotinylated at the cell
surface (membrane), but not that of b1-ARs
or dopamine receptors 1 or 2, in primary rat
hippocampal neurons. Note the time-dependent
decrease of surface b2-AR levels at 6, 18, and
24 hr exposure to 7PA2 CM versus no effect with
24 hr of CHO- CM. TR, biotinylated surface
transferrin receptor as a loading control. (B1)
Representative WB of protein levels. (B2) Sum-
mary data (bars). Protein levels are normalized to
TR for membrane fraction and to GAPDH for
lysate.
Error bars are ±SEM (*p < 0.05; **p < 0.01). See
also Figure S5.
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Environmental Novelty Prevents Ab-Impaired LTPb-AR antagonist, propranolol, to the drinking water (at 0.2 g/l,
as per Cao et al., 2010) of 2-week-old mice undergoing the
4 week EE training. The usual enhancement of LTP by the
4 weeks of EE was now reduced to SH levels (EE + prop:
144% ± 4%, n = 13/13 versus SH: 146% ± 5%, n = 9/5, p >
0.05; Figure 6A). In accord, EE in these propranolol-fed mice
failed to prevent the impairment of LTP by soluble Ab oligomers,
while EE mice who consumed just water resisted the Ab synap-
totoxicity, as before (prop: 114%± 3%, n = 14/12; water: 149%±
6%, n = 14/14; p < 0.001; Figure 6B). Conversely, SH mice
receiving the b-AR agonist isoproterenol (0.1 g/l) in their drinking
water for 4 weeks developed a significant resistance to the LTP-
inhibiting effect of the Ab oligomers (iso: 137% ± 4%, n = 9/8;
water: 113% ± 3%, n = 10/6; p < 0.001; Figure 6C). Similarly,
the iso-fed SH mice showed normal LTP in slices treated with
pure S26C Ab dimers (iso: 141% ± 5%, n = 7; water: 118% ±
3%, n = 7; p < 0.001; Figure 6D). To verify these electrophysio-
logical findings, we also performed quantitative WB on the EE
mice fed propranolol and the SHmice fed isoproterenol. Consis-
tent with the LTP findings, the beneficial biochemical effects of
EE could be significantly decreased by feeding the b-AR antag-
onist propranolol, and they could be mimicked by feeding the
b-AR agonist, isoproterenol, to SH mice (Figures 6E and S6).
Novelty Is More Effective Than Exercise in Preventing
Ab-Induced LTP Inhibition
We next asked whether physical exercise or novelty played
a greater role in the Ab-protective effects of our EE paradigm.
We separated these factors by exposing mice either principally
to physical exercise in large cages containing just two running
wheels (RW group) or principally to cognitive enhancement by
exploringmultiple, changing novel objects in large cages without
running wheels (novelty [Nov] group). Intriguingly, the novelty
group developed significantly increased hippocampal LTP
similar to the levels in our earlier combined EE group, whereas
LTP in the RW group was not significantly different from that ofSH mice (Nov: 180% ± 10%, n = 16/13; RW: 158% ± 6%, n =
13/11; p = 0.049; Figure 7A). In accord, exposure to novelty,
but not to the RW, overcame the inhibition of LTP by cell-derived
human Ab oligomers (Nov: 141% ± 5%, n = 9/9; RW: 119% ±
4%, n = 9/7; p < 0.01; Figure 7B). Similar results were seen
upon treatment of hippocampal slices from the respective
groups with pure synthetic S26C dimers (Nov: 144% ± 6%,
n = 8/6; RW: 127% ± 6%, n = 8/6; versus SH: 112% ± 3%, n =
8; p < 0.05; Figure 7C); here the RW group showed mild protec-
tion against the Ab-mediated inhibition of LTP. These findings
suggest that prolonged and repetitive exploration of a complex
novel environment may beneficially modulate hippocampal
synaptic plasticity and reduce synaptotoxic effects of Ab oligo-
mers in ways that physical exercise alone does not provide.
Prolonged Exposure to EE in Midlife Protects against Ab
Oligomers
To make our findings more relevant to how prolonged exposure
to an enriched cognitive environment might benefit adults with
a propensity to Ab accumulation and eventual development of
AD, we sought to determine whether EE initiated in mature adult
mice could achieve analogous benefits. We began the same EE
training paradigm used at age 2–6 weeks (above) in mice aged
5months. A 4 week EE exposure slightly enhanced hippocampal
LTP, but this did not achieve statistical significance (EE: 177% ±
16%, n = 11/9; SH: 153% ± 8%, n = 8/6; p > 0.05; Figure 7D).
While a 4week EE exposure in adults thus had less robust effects
on the magnitude of LTP than in young animals, the partial resis-
tance of LTP to the inhibitory effects of soluble Ab oligomers did
achieve significance (EE + 7PA2: 128% ± 6%, n = 11/10; SH +
7PA2: 114% ± 4%, n = 9/6: p < 0.05; Figure 7D). To extend
this approach, we next exposed 5-month-old adult mice to an
EE training period of 8 weeks. Now, EE exposure produced
similar benefits to those observed in young mice trained for
4 weeks: LTP in the 8 week EE mice (i.e., at age 7 months)
was 195% ± 9% (n = 20/16) versus 153% ± 7% (n = 11/8) inNeuron 77, 929–941, March 6, 2013 ª2013 Elsevier Inc. 935
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Figure 6. EE-Enhanced LTP Can Be
Mimicked by Prolonged Oral Administration
of a b-Adrenergic Receptor Agonist
(A) Prolonged oral administration of propranolol
(prop, 0.2 g/l) in drinking water during EE training
significantly decreased the EE-enhanced hippo-
campal LTP (red circles, n = 13/13) to levels in SH
mice (gray trace), while EE mice on plain water
(wat) showed the usual LTP enhancement (black
diamonds, n = 9/5).
(B) 7PA2 CMmarkedly inhibited LTP in slices of EE
mice given propranolol in the drinking water (red
circles, n = 14/12), versus the normal LTP in
EE mice on plain water (wat) (black diamonds,
n = 14/14).
(C) Oral administration of isoproterenol (iso, 0.1 g/l)
for 4 wk to SHmicemimicked the EE effect on LTP
(black diamonds, n = 10/7), and iso prevented the
block of LTP by 7PA2 CM (red circles, n = 9/8). The
same 7PA2 CM blocked LTP in SH mice on plain
water (green triangles, n = 10/6).
(D) Giving SHmice iso (0.1 g/l) in drinking water for
4 wk fully prevented the block of LTP by pure Ab
(S26C)2 dimers (5 nM) (red circles, n = 7/7). The
same dimers significantly blocked LTP in SH mice
on plain water (black diamonds, n = 7).
(E) WB of selected signaling proteins in hippo-
campal slices of untreated SH and EE mice, EE
mice fed propranolol, and SH mice fed isoproter-
enol. Representative WB show the protein levels
from hippocampal synaptosomes. Summary
quantification shown in bar graphs.
Error bars represent ±SEM (*p < 0.05; **p < 0.01).
Inset traces as in Figure 1. See also Figure S6.
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Environmental Novelty Prevents Ab-Impaired LTPSH mice (p < 0.001) (Figure 7E). Moreover, the Ab oligomer-
mediated inhibition of LTP was fully prevented (EE + 7PA2 CM:
156% ± 6% [n = 12/12] versus SH + 7PA2 CM: 115% ± 4%
[n = 11/6]; p < 0.001; EE + (S26C)2: 144%± 5% (n = 14/10) versus
SH + (S26C)2: 118% ± 4% (n = 10/8); p < 0.001; Figures 7E
and 7F). We conclude that prolonged environmental enrichment
initiated in adult wt mice significantly enhances hippocampal
synaptic plasticity, providing resistance to the adverse synaptic
effects of soluble Ab oligomers on the hippocampus.
DISCUSSION
With the rising prevalence of AD and the challenge of developing
disease-modifying drugs that can be taken safely for decades,
nonpharmacological approaches to delay the onset of AD or
ameliorate its course deserve intensive study. In mice overex-
pressing mutant human APP and having robust Ab deposition,
a number of reports suggest that exercise and/or EE can936 Neuron 77, 929–941, March 6, 2013 ª2013 Elsevier Inc.decrease AD-like pathology and lessen
behavioral deficits, although there is
disagreement about the effects on plaque
burden and incomplete knowledge of the
responsible mechanisms (see Table S1).
Many late-onset AD cases occur insidi-
ously without known disease-promotinggenetic precipitants, so that a complex mix of environmental
and genetic factors is likely to contribute to their pathogenesis.
We are unaware of prior studies of the potential benefits of EE
in wild-type animals with no genetic diathesis for Ab deposition.
There are also no reports of the effects of EE on the synaptotox-
icity of soluble Ab oligomers per se, yet these species are
believed to be the earliest and most bioactive form of b-amyloid.
By applying soluble oligomers—including those isolated directly
from AD brains—to the hippocampus of wt mice, we distinguish
the effects of EE on synaptic function versus on Ab neuropa-
thology. We demonstrate that EE, and novelty in particular,
potently protect against synaptic impairment by human Ab olig-
omers, in part by activating a b2-adrenoreceptor signaling
pathway that can also be beneficially activated by prolonged
oral administration of a b-AR agonist.
The noradrenergic transmission system is known to partici-
pate in various forms of learning and memory. Activation
of b-ARs was shown to be required for the enhancement of
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Figure 7. Novelty Exposure Prevents Ab Oligomer-Induced LTP Inhibition More Effectively Than Does Exercise, and Midlife EE Is Also
Beneficial
(A) Prolonged exposure to novelty (Nov) (red circles, n = 16/13) significantly enhanced hippocampal LTP to the level of our usual EE paradigm (pink trace), whereas
exposure to just running wheels (RW) (black diamonds, n = 13/11) did not significantly enhance LTP above the level in SH mice (gray trace).
(B) Exposure to novelty (red circles, n = 9/9) but not physical exercise (black diamonds, n = 9/7) significantly prevented LTP inhibition by the Ab oligomer-rich
7PA2 CM.
(C) Novelty (red circles, n = 8/6) fully prevented LTP inhibition by Ab (S26C)2, and physical exercise (RW) did so significantly but less (black diamonds, n = 8/6).
(D) Standard EE training of adult mice from age 5 to 6 months enhanced LTP (black diamonds, n = 11/9) but less than occurred in young mice (c.f. Figures 1C and
1D). This 4 week EE produced modest but significant protection against 7PA2 Ab oligomers (red circles, n = 11/10).
(E) Eight weeks EE in mature adult mice from 5 to 7 months had similar benefit as 4 week EE in youngmice, yielding significant LTP enhancement (pink trace) and
preventing the block of LTP by Ab oligomers (red circles, n = 12/12). As expected, the oligomers strongly inhibited LTP in SH mice at 7 months (black diamonds,
n = 11/6).
(F) EE in adults (5–7 months) fully prevented LTP impairment by Ab (S26C)2 (red circles, n = 14/10) versus the block seen in SH mice (black diamonds, n = 10/8).
Data are means ± SEM. Insets as in Figure 1.
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Environmental Novelty Prevents Ab-Impaired LTPhippocampal LTP by repetitive exploration of a novel environ-
ment (Straube et al., 2003; Kemp and Manahan-Vaughan,
2008; O’Dell et al., 2010). b-AR activation is strongly implicated
in memory storage (McGaugh et al., 1996) and in the benefits
of novelty exposure (King and Williams, 2009; Lemon et al.,
2009). Conversely, b-AR blockade can impair attention,
learning and memory in animals and humans (Cahill et al.,
2000; Chamberlain et al., 2006). In AD brain tissue, decreases
in the levels of b-ARs and norepinephrine have been reported
in several brain regions (Marien et al., 2004; Szot et al., 2006;
Manaye et al., 2013), presumably due in part to the observed
loss of noradrenergic neurons in the locus coeruleus (Grudzien
et al., 2007; Weinshenker, 2008; Manaye et al., 2013). One
possible mechanism for the reduced b-AR levels in AD is
an Ab-induced internalization of the receptors (Wang et al.,
2011), and this is just what we find after the application ofsoluble human Ab oligomers (Figure 5B). Activation of the
b2AR and its downstream cAMP/PKA signaling pathways can
prevent Ab-mediated inhibition of LTP (Wang et al., 2009).
These findings are all consistent with evidence that pharma-
cological enhancement of cAMP/PKA signaling restores
Ab-impaired LTP in both wild-type (Vitolo et al., 2002) and
APP transgenic (Gong et al., 2004) mice. EE can increase
norepinephrine concentrations and strengthen the b-AR
signaling pathways in the brain (Escorihuela et al., 1995;
Naka et al., 2002). All of these data are consistent with our
finding that EE potently protects against Ab oligomer-mediated
synaptic dysfunction. It will now be important to conduct
detailed comparisons of the effects of novel environments
and b-AR stimulation in wt versus APP tg mice, in order to
ascertain the respective effects of EE on Ab homeostasis
versus synaptic structure and function.Neuron 77, 929–941, March 6, 2013 ª2013 Elsevier Inc. 937
Neuron
Environmental Novelty Prevents Ab-Impaired LTPIn this study, mice exposed to novelty alone showed more
electrophysiological benefit than those solely offered running
wheels. This finding may relate to our observation that the
mice moved rapidly among the novel objects they were
exploring, providing two salutary factors (cognitive exploration
and physical activity). Novelty exploration causes an increase
in activity of the locus coeruleus and increases hippocampal
norepinephrine release (Sara et al., 1994). It also increases
several physiological indices of arousal, including heart rate
and blood pressure, as physical exercise does via activation of
the sympathetic nervous system. Our results are consistent
with a report that physical exercise alone was less effective
than novelty training in protecting against cognitive deficits in
APP transgenic mice (Cracchiolo et al., 2007).
Epidemiological studies in humans suggest that environ-
mental influences, including cognitive activity (childhood intelli-
gence, higher education, job complexity), social interactions,
and physical exercise, may all delay the onset of dementia in
AD (Paradise et al., 2009). Our controlled experimental study of
EE in mice at two ages suggests that increased cerebral activity
for 4 weeks early in life contributes a strong protective effect
against Ab oligomer-mediated synaptotoxicity. However, longer
(8 week) EE exposure in our adult animals still provided clear-cut
benefits in terms of resistance to the toxicity of soluble Ab oligo-
mers. Our EE protocols are analogous to prolonged cognitive
and physical activity applied before the onset of significant Ab
accumulation and the consequent development of cognitive
symptoms. Although many humans may miss opportunities for
heightening of cognitive activities earlier in life, our results in
healthy adult mice suggest that benefits can accrue from novelty
exposure in middle age if it is more prolonged and intensive.
These observations are consistent with certain epidemiological
studies of mid- and late-life exposure to enriched or complex
environments that have shown measurable beneficial effects
on cognition and on the risk for AD dementia (Wang et al.,
2002; Verghese et al., 2006). Increased physical activity has
also been shown to protect against late-life cognitive decline
and dementia in several studies (e.g., Lautenschlager et al.,
2008; Baker et al., 2010). Our mechanistic data on EE, particu-
larly novelty, and b-adrenergic stimulation suggest that it may
be possible to ameliorate the early pathophysiological effects
of soluble Ab oligomers in humans by manipulating the environ-
ment. Thus, prolonged presymptomatic behavioral modification
involving cognitive novelty and exercise could complement
Ab-directed and other preventative pharmacological agents to
delay the onset of AD.EXPERIMENTAL PROCEDURES
Animals
The Harvard Medical School Standard Committee on Animals approved all
experiments involving mice used for electrophysiology and biochemical
assays. All mice (male and female) contained a mixed background of C57Bl/
6 and 129. Animals were housed in a temperature-controlled room on
a 12 hr light/12 hr dark cycle and had ad libitum access to food and water.
Environmental Enrichment
Mice at age 14 days were randomly divided into groups of 4–6 placed into
either standard housing (SH) or an enriched environment (EE). SH is a common938 Neuron 77, 929–941, March 6, 2013 ª2013 Elsevier Inc.housing cage (25 3 20 3 15 cm). EE cages are larger (60 3 38 3 20 cm) and
contain 2 running wheels and multiple plastic toys/objects of varying shapes
and colors. The toys were changed daily. Mice were housed in SH or EE for
4 weeks (2 to 6 weeks of age). In some experiments, 5-month-old adult mice
were exposed to EE for either 4 or 8 weeks. The activity of the individual
mice (exploring the objects and/or running on a wheel) was monitored 3–5
times during each 8 hr EE training session; mice showing little voluntary activity
received a tail mark, and a very few animals that persistently showed
no interest in exploratory or running activity were removed from the EE groups.
Control littermate mice were housed in the same room in standard cages
(15 3 25 cm) with only bedding and access to water and food pellets (SH).
Cellular Ab Preparations
Secreted human Ab peptides were collected and prepared from the condi-
tioned media (CM) of a CHO cell line (7PA2) that stably expresses human
APP751 containing the V717F AD mutation (Podlisny et al., 1995). Cells
were grown in Dulbecco’s modified Eagle’s medium (DMEM) containing
10% fetal bovine serum, 1% penicillin/streptomycin, 2 mM L-glutamine, and
200 mg/ml G418 for selection. Upon reaching 95% confluency, the cells
were washed and cultured overnight (15 hr) in serum-free medium. CM
was collected, spun at 1,5003 g to remove dead cells and debris, and stored
at 4C. The CM was concentrated 10-fold with a YM-3 Centricon filter (Walsh
et al., 2005). Aliquots of concentrated 7PA2 CM were stored at –80C.
Disulfide crosslinked dimers of a human Ab1-40 S26C synthetic peptide (gift of
D. Walsh, BWH/HMS) were purified by size-exclusion chromatography.
Immunoprecipitation and Size Exclusion Chromatography
Immunoprecipitation and size exclusion chromatography are described in
Supplemental Experimental Procedures.
Hippocampal Slice Preparation
Mice (C57BL/63 129) in either SH or EE cages were euthanizedwith Isoflurane
at 6 weeks or at 6 or 7 months of age. Brains was quickly removed and
submerged in ice-cold oxygenated sucrose-replaced artificial cerebrospinal
fluid (ACSF) cutting solution (206 mM sucrose, 2 mM KCl, 2 mM MgSO4,
1.25 mM NaH2PO4, 1 mM CaCl2, 1 mM MgCl2, 26 mM NaHCO3, 10 mM
D-glucose [pH 7.4], 315 mOsm. Transverse slices (350 mm thickness) from the
middle portion of each hippocampus were cut with a vibroslicer. After dissec-
tion, slices were incubated in ACSF that contained the following (in mM): 124
NaCl, 2 KCl, 2 MgSO4, 1.25 NaH2PO4, 2.5 CaCl2, 26 NaHCO3, 10 D-glucose
[pH 7.4], 310 mOsm, in which they were allowed to recover for at least 90 min
before recording. A single slice was then transferred to the recording chamber
and submerged beneath continuously perfusing ACSF that had been saturated
with 95% O2 and 5% CO2. Slices were incubated in the recording chamber
for 20 min before stimulation under room temperature (26C).
Electrophysiological Recordings
We used standard procedures to record field excitatory postsynaptic poten-
tials (fEPSP) in the CA1 region of the hippocampus. A bipolar stimulating elec-
trode (FHC Inc., Bowdoin, ME) was placed in the Schaffer collaterals to deliver
test and conditioning stimuli. A borosilicate glass recording electrode filled
with ACSF was positioned in stratum radiatum of CA1, 200300 mm from
the stimulating electrode. fEPSP in the CA1 region were induced by test stimuli
at 0.05 Hz with an intensity that elicited a fEPSP amplitude 40%–50% of
maximum. Test responses were recorded for 30–60 min prior to beginning
the experiment to assure stability of the response. Once a stable test response
was attained, experimental treatments (Ab oligomers, and/or other com-
pounds) were added to the 10 ml ACSF perfusate, and a baseline was re-
corded for an additional 30 min. To induce LTP, two consecutive trains (1 s)
of stimuli at 100 Hz separated by 20 s were applied to the slices, a protocol
that induced LTP lasting approximately 1.5 hr in wild-type mice of this genetic
background. To induce LTD, 300 or 900 pulses were delivered at 1 Hz. The
field potentials were amplified 1003 using an Axon Instruments 200B amplifier
and digitized with Digidata 1322A. Data were sampled at 10 kHz and filtered at
2 kHz. Traces were obtained by pClamp 9.2 and analyzed using the Clampfit
9.2 program. LTP and LTD values reported throughout were measured at
60 min after the conditioning stimulus unless stated otherwise. Paired-pulse
Neuron
Environmental Novelty Prevents Ab-Impaired LTPresponses were monitored at 50 ms interstimulus intervals. The facilitation
ratio was calculated as fEPSP2 slope/fEPSP1 slope. Two-tailed Student’s
t test and one-way analysis of variance (ANOVA) were used to determine
statistical significance.
Whole-Cell Recordings
Whole-cell recordings were made from the soma of visually identified
pyramidal neurons located in CA1 of the hippocampus. Patch pipettes
(5–7 MU) were filled with an internal solution containing (in mM): 110 Cs-gluco-
nate, 20 CsCl, 10 HEPES, 4 NaCl, 0.5 EGTA, 2 MgCl2, 2 Na2ATP, and 0.25
NaGTP, titrated with KOH to pH 7.4, 290–300 mOsm. Series resistance was
kept 15–30 MU and was monitored throughout each recording. Cells were
excluded from data analysis if the series resistance changed by >20% during
the course of the experiment. AMPA-mediated miniature excitatory postsyn-
aptic currents (mEPSCs) were recorded at a holding potential of 70 mV in
the presence of 10 mM bicuculline methiodide (BIC) and TTX (0.5 mM). Con-
tinuous current traces of 5 min duration (recorded at least 10 min after
achieving whole-cell configuration) were analyzed. All patch clamp experi-
ments were performed at room temperature (24C).
Golgi Staining
Golgi staining is described in Supplemental Experimental Procedures.
Preparation of Synaptosome and Cytosolic Fractions and
Quantitative Western Blotting
Synaptosome and cytosolic fractions were prepared as described before (Li
et al., 2011) with minor modifications. Hippocampi and motor cortex were
dissected from mice under different conditions of treatment (n = 6 for SH and
EE), and then the tissues were sectioned by vibratome at 350 mm thickness
andcollected in ice-cold sucrosehomogenizationbuffer (40ml per 10mg tissue)
containing the following (inmM): 320 sucrose, 10 Tris (pH7.4), 1Na3VO4, 5NaF,
1 EDTA, and 1 EGTA. Slices were then homogenized in a glass grinding vessel
using a rotating Teflon pestle (2,000 rpm) with at least 20 passes to create
a Dounce homogenate. The homogenate was centrifuged at 1,000 3 g for
10 min to remove nuclei and incompletely homogenized material (P1). The re-
sulting supernatant (S1) was spun at 10,000 3 g for 15 min to obtain a P2.
The supernatant (S2) was defined as cytosolic fraction. The P2 was subse-
quently resuspended in 120 ml sucrose buffer using a motorized pestle mix-
ing/grinding rod (Kontes) directly in the microfuge tube with 30 pulses. The
P2 was then subjected to detergent extraction by adding 8 vol of Triton
X-100 buffer (final = 0.5% v/v) containing the following reagents (in mM): 10
Tris (pH 7.4), 1 Na3VO4, 5 NaF, 1 EDTA, and 1 EGTA. This suspensionwas incu-
bated at 4C for 20minwith gentle.We operationally defined the suspension as
the synaptosome fraction. Protein concentrations were determined using the
bicinchoninic acid (BCA) assay. We loaded 20 mg of total protein in each lane,
separated by 4%–12%SDS-PAGE and blotted onto nitrocellulose membrane.
Theblotwasblocked for 1 hr at RT, followedby incubation overnight at 4Cwith
rabbit polyclonal antibodies: GluN1 (Millipore), GluN2A (Millipore), GluN2B
(Invitrogen), GluA1 (Millipore), GluA1 pS845 (Thermo), Synapsin I (Millipore),
p-CREB (Millipore), p-ERK1/2 (Cell Signaling), p-CaMKII (Millipore), b2-adren-
ergic receptor (Thermo), b1-adrenergic receptor (Thermo), b2-adrenergic
receptor Thr384 (Millipore), Dopamine Receptor 1 (Millipore), Dopamine
Receptor 2 (Millipore), AchRM1 (Millipore), AchRM2 (Millipore), 5HTR 1B (Milli-
pore), 5HTR 2B (Millipore), ormousemonoclonal antibodies: PSD95 (Millipore),
Synaptophysin (Millipore), GAPDH (Millipore). Membranes were rinsed and
incubated for 1 hr with fluorescence-conjugated goat anti-rabbit or mouse
IgG (1:5,000; Invitorgen). Blots were scanned using a Li-Cor Odyssey system.
Immunohistochemistry and Confocal Microscopy
Immunohistochemistry and confocal microscopy are described in Supple-
mental Experimental Procedures.
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